No abstract available
MeSH terms
-
Animals
-
Bone Marrow Transplantation / adverse effects
-
Cattle
-
Cell Line, Transformed
-
Cornea / metabolism
-
Cornea / pathology
-
Endothelial Cells / metabolism*
-
Endothelial Cells / pathology
-
Fibrinolytic Agents / pharmacology*
-
Fibrinolytic Agents / therapeutic use
-
Fibroblast Growth Factor 2 / metabolism*
-
Hepatic Veno-Occlusive Disease / drug therapy
-
Hepatic Veno-Occlusive Disease / etiology
-
Hepatic Veno-Occlusive Disease / metabolism*
-
Hepatic Veno-Occlusive Disease / pathology
-
Humans
-
Multiple Organ Failure / drug therapy
-
Multiple Organ Failure / etiology
-
Multiple Organ Failure / metabolism
-
Multiple Organ Failure / pathology
-
Neovascularization, Physiologic / drug effects*
-
Polydeoxyribonucleotides / pharmacology*
-
Polydeoxyribonucleotides / therapeutic use
-
Protein Binding / drug effects
-
Receptor, Fibroblast Growth Factor, Type 3 / metabolism
-
Vascular Endothelial Growth Factor A / metabolism
Substances
-
Fibrinolytic Agents
-
Polydeoxyribonucleotides
-
Vascular Endothelial Growth Factor A
-
Fibroblast Growth Factor 2
-
defibrotide
-
FGFR3 protein, human
-
Receptor, Fibroblast Growth Factor, Type 3